Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

182 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Discovery of a Good Responder Subtype of Esophageal Squamous Cell Carcinoma with Cytotoxic T-Lymphocyte Signatures Activated by Chemoradiotherapy.
Tanaka Y, Aoyagi K, Minashi K, Komatsuzaki R, Komatsu M, Chiwaki F, Tamaoki M, Nishimura T, Takahashi N, Oda I, Tachimori Y, Arao T, Nishio K, Kitano S, Narumi K, Aoki K, Fujii S, Ochiai A, Yoshida T, Muto M, Yamada Y, Sasaki H. Tanaka Y, et al. Among authors: tamaoki m. PLoS One. 2015 Dec 1;10(12):e0143804. doi: 10.1371/journal.pone.0143804. eCollection 2015. PLoS One. 2015. PMID: 26625258 Free PMC article.
SIX1 maintains tumor basal cells via transforming growth factor-β pathway and associates with poor prognosis in esophageal cancer.
Nishimura T, Tamaoki M, Komatsuzaki R, Oue N, Taniguchi H, Komatsu M, Aoyagi K, Minashi K, Chiwaki F, Shinohara H, Tachimori Y, Yasui W, Muto M, Yoshida T, Sakai Y, Sasaki H. Nishimura T, et al. Among authors: tamaoki m. Cancer Sci. 2017 Feb;108(2):216-225. doi: 10.1111/cas.13135. Cancer Sci. 2017. PMID: 27987372 Free PMC article.
Comprehensive genomic profiling for patients with chemotherapy-naïve advanced cancer.
Kondo T, Matsubara J, Quy PN, Fukuyama K, Nomura M, Funakoshi T, Doi K, Sakamori Y, Yoshioka M, Yokoyama A, Tamaoki M, Kou T, Hirohashi K, Yamada A, Yamamoto Y, Minamiguchi S, Nishigaki M, Yamada T, Kanai M, Matsumoto S, Muto M. Kondo T, et al. Among authors: tamaoki m. Cancer Sci. 2021 Jan;112(1):296-304. doi: 10.1111/cas.14674. Epub 2020 Nov 21. Cancer Sci. 2021. PMID: 33007138 Free PMC article.
Assessment of the Diagnostic Performance of Endoscopic Ultrasonography After Conventional Endoscopy for the Evaluation of Esophageal Squamous Cell Carcinoma Invasion Depth.
Ishihara R, Mizusawa J, Kushima R, Matsuura N, Yano T, Kataoka T, Fukuda H, Hanaoka N, Yoshio T, Abe S, Yamamoto Y, Nagata S, Ono H, Tamaoki M, Yoshida N, Takizawa K, Muto M. Ishihara R, et al. Among authors: tamaoki m. JAMA Netw Open. 2021 Sep 1;4(9):e2125317. doi: 10.1001/jamanetworkopen.2021.25317. JAMA Netw Open. 2021. PMID: 34524432 Free PMC article.
Second gastric cancer after curative endoscopic resection of differentiated-type early gastric cancer: post-hoc analysis of a single-arm confirmatory trial.
Yoshida M, Takizawa K, Hasuike N, Ono H, Boku N, Kadota T, Mizusawa J, Oda I, Yoshida N, Horiuchi Y, Hirasawa K, Morita Y, Yamamoto Y, Muto M; Gastrointestinal Endoscopy Group of the Japan Clinical Oncology Group. Yoshida M, et al. Gastrointest Endosc. 2022 Apr;95(4):650-659. doi: 10.1016/j.gie.2021.11.050. Epub 2021 Dec 15. Gastrointest Endosc. 2022. PMID: 34919940
Association between homologous recombination gene variants and efficacy of oxaliplatin-based chemotherapy in advanced pancreatic cancer: prospective multicenter observational study.
Kondo T, Kanai M, Matsubara J, Yamaguchi D, Ura T, Kou T, Itani T, Nomura M, Funakoshi T, Yokoyama A, Doi K, Tamaoki M, Yoshimura M, Uza N, Yamada T, Masui T, Minamiguchi S, Matsumoto S, Ishikawa H, Muto M. Kondo T, et al. Among authors: tamaoki m. Med Oncol. 2023 Apr 11;40(5):144. doi: 10.1007/s12032-023-02011-y. Med Oncol. 2023. PMID: 37039943
182 results